Rheumatology Advisor2h
JAK Inhibitors Often Used to Treat JDM, Despite Data Gaps and Access Barriers
The off-label use of JAK inhibitors to treat JDM is common in pediatric rheumatology, with barriers to use including limited clinical trial data and insurance approval.
Dermatology Advisor4h
JAK Inhibitors Linked to Increased Lung Cancer Risk in Older Patients With RA
Janus kinase (JAK) inhibitors are associated with an increased risk for lung cancer but not overall cancer among older patients in the United States with rheumatoid arthritis (RA), according to study ...
The American Journal of Managed Care1d
New Studies Highlight JAK Inhibitors’ Power as AD Treatment
Janus kinase (JAK) inhibitors, including ruxolitinib cream and abrocitinib, demonstrate strong efficacy in atopic dermatitis ...
eLife1d
Nora virus proliferates in dividing intestinal stem cells and sensitizes flies to intestinal infection and oxidative stress
This important study shows that the Nora virus, a natural Drosophila pathogen that also persistently infects many laboratory fly stocks, infects intestinal stem cells (ISCs), leading to a shorter life ...
Scientists uncover novel immune mechanism of wheat tandem kinase
Researchers have unveiled a novel immune mechanism by which tandem kinases combat pathogen invasion: an atypical NLR protein, ...
Pharmaceutical Technology6d
AGA overhauls UC treatment pathway: early, high-efficacy therapies now preferred
In December 2024, the American Gastroenterological Association (AGA) published an updated clinical guideline for the ...